Similar mortality rates for early and late group B streptococcal disease among newborns at Groote Schuur Hospital in Cape Town
Article Sidebar
Main Article Content
Abstract
Background. Invasive group B streptococcal disease (iGBS) is an important cause of morbidity and mortality in newborns globally and is more common in Sub-Saharan Africa and South Africa. Few studies describe newborn iGBS cases in the Western Cape, leaving limited data to guide local prevention and treatment strategies.
Objective. To describe all cases of newborn iGBS at Groote Schuur Hospital (GSH), Western Cape, between January 2015 and December 2020. Methods. A retrospective review was conducted of all blood or cerebrospinal fluid-positive cases of newborn iGBS between January 2015 and December 2020.
Results. Thirty-five cases of iGBS were included in the study, 51% with early-onset disease (EoD) and 49% with late-onset disease (LoD). The median gestational age at birth was 27 and 31.5 weeks in the LoD and EoD groups, respectively. The median birth weight was 900 g and 1 812 g in the LoD and EoD groups, respectively. Meningitis was more common in the LoD group and pneumonia was more common in the EoD group. The overall mortality rate was 23%, with similar mortality rates in the EoD and LoD groups (22% and 24%, respectively). Invasive GBS disease accounted for a cumulative 274 intensive care unit days during the study period.
Conclusion. Invasive GBS disease in newborns at GSH is associated with a high mortality rate, with this study showing similar mortality rates between the EoD and LoD groups.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. Glaser P, Rusniok C, Buchrieser C, et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 2002;45(6):1499-1513. https://doi.org/10.1046/j.1365-2958.2002.03126.x
2. Seale AC, Bianchi-Jassir F, Russell NJ, et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis 2017;65(Suppl 2):S200-219. https://doi.org/10.1093/cid/cix664
3. Gonçalves BP, Procter SR, Paul P, et al. Group B Streptococcus infection during pregnancy and infancy: Estimates of regional and global burden. Lancet Glob Health 2022;10(6):e807-819. https://doi.org/10.1016/s2214-109x(22)00093-6
4. Kohli-Lynch M, Russell NJ, Seale AC, et al. Neurodevelopmental impairment in children after group B streptococcal disease worldwide: Systematic review and meta-analyses. Clin Infect Dis 2017;65(Suppl 2):S190-199. https://doi. org/10.1093/cid/cix663
5. Kwatra G, Cunnington MC, Merrall E, et al. Prevalence of maternal colonisation with group B Streptococcus: A systematic review and meta-analysis. Lancet Infect Dis 2016;16(9):1076-1084. https://doi.org/10.1016/s1473-3099(16)30055-x
6. Cutland CL, Schrag SJ, Thigpen MC, et al. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004–20081. Emerg Infect Dis 2015;21(4):638-645. https://doi.org/10.3201/ eid2104.141562
7. Madhi SA, Anderson AS, Absalon J, et al. Potential for maternally administered vaccine for infant group B Streptococcus. N Engl J Med 2023;389(3):215-227. https://doi.org/10.1056/nejmoa2116045
8. Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obs Gynecol 2013;121(3):570-577. https://doi.org/10.1097/aog.0b013e318280d4f6
9. Quan V, Verani JR, Cohen C, Von Gottberg A, et al. Invasive group B streptococcal disease in South Africa: Importance of surveillance methodology. PLoS One 2016;11(4):1-10. https://doi.org/10.1371/journal.pone.0152524
10. Sinha A, Russell LB, Tomczyk S, et al. Disease burden of group B Streptococcus among infants in sub-Saharan Africa: A systematic literature review and meta- analysis. Pediatr Infect Dis J 2016;35(9):933-942. https://doi.org/10.1097/ inf.0000000000001233
11. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Lancet 2012;379(9815):547-556. https://doi.org/10.1016/s0140-6736(11)61651-612. Dangor Z, Lala SG, Cutland CL, et al. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One 2015;10(4):1-13. https://doi.org/10.1371/journal.pone.0123014
13. Frigati L, Merwe JL Van Der, Harvey J, et al. A retrospective review of group B streptococcal infection in the Metro East area of the Western Cape province: 2010 to 2011. S Afr J Infect Dis 2015;29(1):33-36. https://hdl.handle. net/10520/EJC155247
14. Paul P, Chandna J, Procter SR, et al. Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina. Lancet eClin Med 2022;47:101358. https://doi.org/10.1016/j.eclinm.2022.101358
15. South African Department of Health. The 2019 National Antenatal HIV Sentinel Survey (ANCHSS) Key Findings. 2021.
16. National Department of Health (NDoH). Guidelines for Maternity Care in South Africa: A manual for clinics, community health centres and district hospitals. South African Government. 2015:174. Maternal-Care- Guidelines-2015_FINAL-21.7.15.pdf
17. Dangor Z, Lala SG, Madhi SA. Preventing invasive group B Streptococcus (GBS) disease in South African infants: Time for change. S Afr J Child Health 2015;9(3):69-70. http://dx.doi.org/10.7196/SAJCH.8575
18. Joolay Y, Horn A. Neonatal Guidelines and Drug Doses. 5th ed. Cape Town: Department of Neonatal Medicine, Groote Schuur Hospital. 2020.
19. Stafford IA, Rodrigue E, Berra A, et al. The strong correlation between neonatal early-onset group B Streptococcal disease and necrotizing enterocolitis. Obs Gynecol Reprod Biol 2018;223:93-97. https://doi.org/10.1016/j.ejogrb. 2018.02.024
20. Hofer N, Müller W. An update on the use of c-reactive protein in early-onset neonatal sepsis : Neonatology 2012;102:25-36. https://doi. org/10.1159/000336629